» Articles » PMID: 19728363

Common Epigenetic Changes of D4Z4 in Contraction-dependent and Contraction-independent FSHD

Overview
Journal Hum Mutat
Specialty Genetics
Date 2009 Sep 4
PMID 19728363
Citations 117
Authors
Affiliations
Soon will be listed here.
Abstract

Facioscapulohumeral muscular dystrophy (FSHD), caused by partial deletion of the D4Z4 macrosatellite repeat on chromosome 4q, has a complex genetic and epigenetic etiology. To develop FSHD, D4Z4 contraction needs to occur on a specific genetic background. Only contractions associated with the 4qA161 haplotype cause FSHD. In addition, contraction of the D4Z4 repeat in FSHD patients is associated with significant D4Z4 hypomethylation. To date, however, the methylation status of contracted repeats on nonpathogenic haplotypes has not been studied. We have performed a detailed methylation study of the D4Z4 repeat on chromosome 4q and on a highly homologous repeat on chromosome 10q. We show that patients with a D4Z4 deletion (FSHD1) have D4Z4-restricted hypomethylation. Importantly, controls with a D4Z4 contraction on a nonpathogenic chromosome 4q haplotype or on chromosome 10q also demonstrate hypomethylation. In 15 FSHD families without D4Z4 contractions but with at least one 4qA161 haplotype (FSHD2), we observed D4Z4-restricted hypomethylation on chromosomes 4q and 10q. This finding implies that a genetic defect resulting in D4Z4 hypomethylation underlies FSHD2. In conclusion, we describe two ways to develop FSHD: (1) contraction-dependent or (2) contraction-independent D4Z4 hypomethylation on the 4qA161 subtelomere.

Citing Articles

Double trouble: a comprehensive study into unrelated genetic comorbidities in adult patients with Facioscapulohumeral Muscular Dystrophy Type I.

Puma A, Tammam G, Ezaru A, Slioui A, Torchia E, Tasca G Eur J Hum Genet. 2025; .

PMID: 39775061 DOI: 10.1038/s41431-024-01770-0.


Facioscapulohumeral Dystrophy: Molecular Basis and Therapeutic Opportunities.

Arends T, Hamm D, van der Maarel S, Tapscott S Cold Spring Harb Perspect Biol. 2024; .

PMID: 39009417 PMC: 11733064. DOI: 10.1101/cshperspect.a041492.


French National Protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD).

Attarian S, Beloribi-Djefaflia S, Bernard R, Nguyen K, Cances C, Gavazza C J Neurol. 2024; 271(9):5778-5803.

PMID: 38955828 DOI: 10.1007/s00415-024-12538-3.


Engineered FSHD mutations results in D4Z4 heterochromatin disruption and feedforward DUX4 network activation.

Kong X, Nguyen N, Li Y, Sakr J, Williams K, Sharifi S iScience. 2024; 27(4):109357.

PMID: 38510139 PMC: 10951985. DOI: 10.1016/j.isci.2024.109357.


IL-6 and TNF are Potential Inflammatory Biomarkers in Facioscapulohumeral Muscular Dystrophy.

Greco A, Mul K, Jaeger M, Dos Santos J, Koenen H, de Jong L J Neuromuscul Dis. 2024; 11(2):327-347.

PMID: 38250782 PMC: 10977382. DOI: 10.3233/JND-230063.